PortfoliosLab logoPortfoliosLab logo
APYX vs. AMPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

APYX vs. AMPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apyx Medical Corporation (APYX) and Amplify Energy Corp. (AMPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, APYX achieves a 17.14% return, which is significantly higher than AMPY's -14.44% return.


APYX

1D
-0.49%
1M
-4.65%
6M
1.99%
YTD
17.14%
1Y
134.29%
3Y*
-9.49%
5Y*
-14.55%
10Y*
ALL TIME*
-8.39%

AMPY

1D
4.27%
1M
-2.25%
6M
-22.11%
YTD
-14.44%
1Y
7.71%
3Y*
-19.26%
5Y*
3.51%
10Y*
20.77%
ALL TIME*
-7.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$2.39M$2.39M$3.41M
$248.17K$250.43K$617.49K

APYX vs. AMPY - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
APYX
Apyx Medical Corporation
17.14%121.52%-39.69%11.97%-81.75%78.06%-14.89%6.28%
AMPY
Amplify Energy Corp.
-14.44%-23.83%1.18%-32.54%182.64%137.40%-77.85%-5.47%

Correlation

The correlation between APYX and AMPY is -0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.02

Correlation (3Y)
Balances recent behavior with more history.

0.00

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.06

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2019

0.13

The correlation between APYX and AMPY shifts across timeframes, from -0.02 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

APYX:

$172.65M

AMPY:

$161.43M

EPS

APYX:

-$0.33

AMPY:

$0.29

PS Ratio

APYX:

2.03

AMPY:

0.70

Total Revenue (TTM)

APYX:

$55.83M

AMPY:

$228.78M

Gross Profit (TTM)

APYX:

$21.29M

AMPY:

$131.23M

EBITDA (TTM)

APYX:

-$3.18M

AMPY:

$84.62M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

APYX vs. AMPY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

APYX
APYX Risk / Return Rank: 8585
Overall Rank
APYX Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
APYX Sortino Ratio Rank: 8686
Sortino Ratio Rank
APYX Omega Ratio Rank: 8181
Omega Ratio Rank
APYX Calmar Ratio Rank: 8888
Calmar Ratio Rank
APYX Martin Ratio Rank: 8888
Martin Ratio Rank

AMPY
AMPY Risk / Return Rank: 4646
Overall Rank
AMPY Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
AMPY Sortino Ratio Rank: 4747
Sortino Ratio Rank
AMPY Omega Ratio Rank: 4646
Omega Ratio Rank
AMPY Calmar Ratio Rank: 4646
Calmar Ratio Rank
AMPY Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

APYX vs. AMPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Amplify Energy Corp. (AMPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


APYXAMPYDifference
Sharpe ratioReturn per unit of total volatility

+1.39

Sortino ratioReturn per unit of downside risk

+1.90

Omega ratioGain probability vs. loss probability

1.27

1.06

+0.21

Calmar ratioReturn relative to maximum drawdown

3.15

0.07

+3.09

Martin ratioReturn relative to average drawdown

8.56

0.14

+8.42

APYX vs. AMPY - Sharpe Ratio Comparison

The current APYX Sharpe Ratio is 1.44, which is higher than the AMPY Sharpe Ratio of 0.05. The chart below compares the historical Sharpe Ratios of APYX and AMPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

APYX vs. AMPY - Drawdown Comparison

The maximum APYX drawdown since its inception was -94.99%, roughly equal to the maximum AMPY drawdown of -97.31%. Use the drawdown chart below to compare losses from any high point for APYX and AMPY.


Loading charts...

Drawdown Indicators


APYXAMPYDifference

Max Drawdown

Largest peak-to-trough decline

-94.99%

-97.31%

+2.32%

Max Drawdown (1Y)

Largest decline over 1 year

-36.59%

-44.65%

+8.06%

Max Drawdown (3Y)

Largest decline over 3 years

-82.74%

-71.11%

-11.63%

Max Drawdown (5Y)

Largest decline over 5 years

-94.99%

-77.47%

-17.52%

Max Drawdown (10Y)

Largest decline over 10 years

-97.24%

Current Drawdown

Current decline from peak

-76.44%

-79.28%

+2.84%

Average Drawdown

Average peak-to-trough decline

-57.33%

-66.52%

+9.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.46%

21.34%

-7.88%

Volatility

APYX vs. AMPY - Volatility Comparison

Apyx Medical Corporation (APYX) has a higher volatility of 17.96% compared to Amplify Energy Corp. (AMPY) at 13.30%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than AMPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


APYXAMPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.96%

13.30%

+4.66%

Volatility (6M)

Calculated over the trailing 6-month period

55.31%

40.50%

+14.81%

Volatility (1Y)

Calculated over the trailing 1-year period

80.07%

61.71%

+18.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

100.64%

66.56%

+34.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.69%

980.20%

-887.51%

Dividends

APYX vs. AMPY - Dividend Comparison

Neither APYX nor AMPY has paid dividends to shareholders.


PositionTTM2025202420232022202120202019
AMPY
Amplify Energy Corp.
0.00%0.00%0.00%0.00%0.00%0.00%7.63%6.05%
APYX
Apyx Medical Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

APYX vs. AMPY - Financials Comparison

This section allows you to compare key financial metrics between Apyx Medical Corporation and Amplify Energy Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


APYX and AMPY have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APYX has higher volatility (17.96%) compared to AMPY (13.30%). In terms of maximum drawdown, APYX dropped -94.99% vs AMPY's -97.31%.

APYX currently has the higher Sharpe Ratio (1.44 vs 0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for APYX and AMPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer